In bladder cancer cells, IP3R1 expression level has been inversely correlated to cisplatin-resistance: resistant cells express reduced IP3R1 level, and IP3R1-knockdown prevents apoptosis, leading to cisplatin resistance. This evidence concerns the gene ITPR1 and urinary bladder carcinoma.